speb/financial-data huggingface dataset:
AMRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 72057000.00
AMRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 35076000.00
AMRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 127933000.00
AMRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 49573000.00
AMRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 127933000.00
AMRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 49573000.00
AMRX cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -15514000.00
AMRX cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -3000000.00
AMRX income_statement (annual, 2025-12-31) — Net Interest Income: -272456000.00
AMRX income_statement (quarterly, 2025-12-31) — Net Interest Income: -56237000.00
AMRX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 101242000.00
AMRX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -6124000.00
AMRX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2694750000.00
AMRX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 2805384000.00
AMRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -272456000.00
AMRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -56237000.00
AMRX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -134732000.00
AMRX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -4549000.00
AMRX balance_sheet (annual, 2025-12-31) — Net PPE: 550326000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 550326000.00
AMRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -96749000.00
AMRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -42454000.00
AMRX cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -2593508000.00
AMRX cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -2811508000.00
AMRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -1229762000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1229762000.00
AMRX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 5197000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 5197000.00
AMRX balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 37547000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 37547000.00
AMRX income_statement (annual, 2025-12-31) — Normalized EBITDA: 606643000.00
AMRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 176895000.00
AMRX income_statement (annual, 2025-12-31) — Normalized Income: 74603549.00
AMRX income_statement (quarterly, 2025-12-31) — Normalized Income: 49611789.05
AMRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 339992000.00
AMRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 130315000.00
AMRX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -7453000.00
AMRX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 1153000.00
AMRX income_statement (annual, 2025-12-31) — Operating Income: 397914000.00
AMRX income_statement (quarterly, 2025-12-31) — Operating Income: 114503000.00
AMRX income_statement (annual, 2025-12-31) — Operating Revenue: 3018760000.00
AMRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 814319000.00
AMRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 314565000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 314565000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 6761000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 6761000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 43256000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 43256000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -110729000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -110729000.00
AMRX income_statement (annual, 2025-12-31) — Other Income Expense: 13751000.00
AMRX income_statement (quarterly, 2025-12-31) — Other Income Expense: -3031000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 563498000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 563498000.00
AMRX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 59757000.00
AMRX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 7814000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 9305000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 9305000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 92728000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 92728000.00
AMRX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 16522000.00
AMRX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 13165000.00
AMRX income_statement (annual, 2025-12-31) — Other Operating Expenses: -5240000.00
AMRX income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -1000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Properties: 107376000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 107376000.00
AMRX balance_sheet (annual, 2025-12-31) — Other Receivables: 25599000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 25599000.00
AMRX income_statement (annual, 2025-12-31) — Other Special Charges: 6198000.00
AMRX income_statement (quarterly, 2025-12-31) — Other Special Charges: 12289000.00
AMRX balance_sheet (annual, 2025-12-31) — Payables: 310156000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Payables: 310156000.00
AMRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 736915000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 736915000.00
AMRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 79886000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 79886000.00
AMRX balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 77292000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 77292000.00
AMRX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
AMRX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
AMRX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 54134000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 54134000.00
AMRX income_statement (annual, 2025-12-31) — Pretax Income: 139209000.00
AMRX income_statement (quarterly, 2025-12-31) — Pretax Income: 55235000.00
AMRX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1960000.00
AMRX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 553000.00
AMRX balance_sheet (annual, 2025-12-31) — Properties: 0.00
AMRX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
AMRX cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 85962000.00
AMRX cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 26636000.00
AMRX cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -15514000.00
AMRX cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -3000000.00
AMRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -98843000.00
AMRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -43169000.00
AMRX balance_sheet (annual, 2025-12-31) — Raw Materials: 227353000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 227353000.00
AMRX balance_sheet (annual, 2025-12-31) — Receivables: 939874000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Receivables: 939874000.00
AMRX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1905452000.00
AMRX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 517129000.00
AMRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 223572000.00
AMRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 49227000.00
AMRX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2811508000.00
AMRX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -6124000.00
AMRX income_statement (annual, 2025-12-31) — Research And Development: 193807000.00
AMRX income_statement (quarterly, 2025-12-31) — Research And Development: 36230000.00
AMRX balance_sheet (annual, 2025-12-31) — Restricted Cash: 28842000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 28842000.00
AMRX income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 4208000.00
AMRX income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 2470000.00
AMRX balance_sheet (annual, 2025-12-31) — Retained Earnings: -535005000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -535005000.00
AMRX cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
AMRX cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
AMRX cash_flow (annual, 2025-12-31) — Sale Of PPE: 2094000.00
AMRX cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 715000.00
AMRX income_statement (annual, 2025-12-31) — Selling General And Administration: 526827000.00
AMRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 146458000.00
AMRX balance_sheet (annual, 2025-12-31) — Share Issued: 314565000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 314565000.00
AMRX cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 218000000.00
AMRX cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 0.00
AMRX cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -2811508000.00
AMRX income_statement (annual, 2025-12-31) — Special Income Charges: -10406000.00
AMRX income_statement (quarterly, 2025-12-31) — Special Income Charges: -14759000.00
AMRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 31953000.00
AMRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 8202000.00
AMRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: -70794000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -70794000.00
AMRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: -1229762000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1229762000.00
AMRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -224451.00
AMRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -1660210.95
AMRX income_statement (annual, 2025-12-31) — Tax Provision: 11276000.00
AMRX income_statement (quarterly, 2025-12-31) — Tax Provision: 5662000.00
AMRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.08
AMRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.10
AMRX balance_sheet (annual, 2025-12-31) — Taxes Receivable: 18662000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 18662000.00
AMRX balance_sheet (annual, 2025-12-31) — Total Assets: 3678280000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 3678280000.00
AMRX balance_sheet (annual, 2025-12-31) — Total Capitalization: 2494321000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2494321000.00
AMRX balance_sheet (annual, 2025-12-31) — Total Debt: 2689046000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 2689046000.00
AMRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -71329000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -71329000.00
AMRX income_statement (annual, 2025-12-31) — Total Expenses: 2620846000.00
AMRX income_statement (quarterly, 2025-12-31) — Total Expenses: 699816000.00
AMRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3749609000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3749609000.00
AMRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1767099000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1767099000.00
AMRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2867976000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2867976000.00
AMRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 394096000.00
AMRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 112033000.00
AMRX income_statement (annual, 2025-12-31) — Total Other Finance Cost: 31365000.00
AMRX income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 0.00
AMRX income_statement (annual, 2025-12-31) — Total Unusual Items: -2771000.00
AMRX income_statement (quarterly, 2025-12-31) — Total Unusual Items: -16196000.00
AMRX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2771000.00
AMRX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -16196000.00
AMRX balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
AMRX balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
AMRX balance_sheet (annual, 2025-12-31) — Work In Process: 55455000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Work In Process: 55455000.00
AMRX balance_sheet (annual, 2025-12-31) — Working Capital: 1029548000.00
AMRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 1029548000.00
AMRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 171844000.00
AMRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 722519000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 227675000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 850860000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 536299000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -676146000.00
AMRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 316023000.00
AMRX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.20
AMRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 312939000.00
AMRX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -21710000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 124729000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3190000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 197656000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 197656000.00
AMRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -59055000.00
AMRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -21710000.00
AMRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -26743000.00
AMRX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -124578000.00
AMRX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -54959000.00
AMRX cash_flow (quarterly, 2026-03-31) — Change In Payable: -165680000.00
AMRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -165680000.00
AMRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -13400000.00
AMRX cash_flow (quarterly, 2026-03-31) — Change In Receivables: 43957000.00
AMRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -190082000.00
AMRX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 44013000.00
AMRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -107508000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 3190000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -45411000.00
AMRX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 402406000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 381029000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 1797907000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 15285000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Current Debt: 6200000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 21485000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 728049000.00
AMRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 43191000.00
AMRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 43191000.00
AMRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 328933000.00
AMRX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.19
AMRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 62256000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 508000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 33039000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Non Current: 456000.00
AMRX income_statement (quarterly, 2026-03-31) — EBIT: 133537000.00
AMRX income_statement (quarterly, 2026-03-31) — EBITDA: 176728000.00
AMRX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1023000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 10852000.00
AMRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 204408000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Financial Assets: 10150000.00
AMRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -59055000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Finished Goods: 349413000.00
AMRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -48453000.00
AMRX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -7800000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -112151000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Goodwill: 593800000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1128669000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1527006000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 558762000.00
AMRX income_statement (quarterly, 2026-03-31) — Gross Profit: 320113000.00
AMRX income_statement (quarterly, 2026-03-31) — Interest Expense: 53361000.00
AMRX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 53361000.00
AMRX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 56450000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Interest Payable: 7975000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Inventory: 641618000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2526347000.00
AMRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -21710000.00
AMRX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 134673000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 109444000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2565558000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2675002000.00
AMRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 134673000.00
AMRX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -140842000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Minority Interest: -558000.00
AMRX income_statement (quarterly, 2026-03-31) — Minority Interests: -15744000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Net Debt: 2374102000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 8215000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Income: 62256000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 62256000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 78000000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 62256000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 62256000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 78000000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 78000000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -7850000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Interest Income: -56871000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -6169000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -6169000.00
AMRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -56871000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -52924000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 558762000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -13860000.00
AMRX cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
AMRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -1174080000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 4910000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 14663000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 14663000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 32008000.00
AMRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 188692000.00
AMRX income_statement (quarterly, 2026-03-31) — Normalized Income: 73896972.00
AMRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -26743000.00
AMRX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 8215000.00
AMRX income_statement (quarterly, 2026-03-31) — Operating Income: 148269000.00
AMRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 722519000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 318998000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 6200000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 10550000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -112151000.00
AMRX income_statement (quarterly, 2026-03-31) — Other Income Expense: -11222000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 534869000.00
AMRX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 11764000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7812000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 71253000.00
AMRX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 742000.00
AMRX income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -6941000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Properties: 558762000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 31279000.00
AMRX income_statement (quarterly, 2026-03-31) — Other Special Charges: -1639000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Payables: 260714000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 641743000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 54271000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 85912000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
AMRX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 51807000.00
AMRX income_statement (quarterly, 2026-03-31) — Pretax Income: 80176000.00
AMRX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 38000.00
AMRX cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 13353000.00
AMRX cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -7850000.00
AMRX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -13860000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Raw Materials: 229124000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Receivables: 902652000.00
AMRX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 402406000.00
AMRX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 43191000.00
AMRX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -140842000.00
AMRX income_statement (quarterly, 2026-03-31) — Research And Development: 39925000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 4174000.00
AMRX income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 5803000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -472749000.00
AMRX cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
AMRX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 138860000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Share Issued: 318998000.00
AMRX cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
AMRX income_statement (quarterly, 2026-03-31) — Special Income Charges: -4164000.00
AMRX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8816000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -45411000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -1174080000.00
AMRX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -323028.00
AMRX income_statement (quarterly, 2026-03-31) — Tax Provision: 2176000.00
AMRX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.03
AMRX balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 20005000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Total Assets: 3540218000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2520147000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Total Debt: 2696487000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -45969000.00
AMRX income_statement (quarterly, 2026-03-31) — Total Expenses: 574250000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3586187000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1742311000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2858138000.00
AMRX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 141772000.00
AMRX income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 3510000.00
AMRX income_statement (quarterly, 2026-03-31) — Total Unusual Items: -11964000.00
AMRX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -11964000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 0.00
AMRX balance_sheet (quarterly, 2026-03-31) — Work In Process: 63081000.00
AMRX balance_sheet (quarterly, 2026-03-31) — Working Capital: 1069858000.00
AMRZ income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 22000000.00
AMRZ income_statement (annual, 2022-12-31) — +Operating Expense: 752000000.00
AMRZ income_statement (annual, 2022-12-31) — +Total Revenue: 10726000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Accounts Payable: 1144000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Accounts Receivable: 963000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -7938000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -31000000.00
AMRZ cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 57000000.00
AMRZ income_statement (annual, 2022-12-31) — Basic Average Shares: 552700000.00
AMRZ income_statement (annual, 2022-12-31) — Basic EPS: 2.00
AMRZ cash_flow (annual, 2022-12-31) — Beginning Cash Position: 399000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2765000000.00
AMRZ cash_flow (annual, 2022-12-31) — Capital Expenditure: -488000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 689000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 351000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 351000000.00
AMRZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 497000000.00
AMRZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2521000000.00
AMRZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1988000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Account Payable: 195000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Inventory: -296000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -62000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 115000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -27000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Payable: 249000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 249000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Receivables: 35000000.00
AMRZ cash_flow (annual, 2022-12-31) — Change In Working Capital: 14000000.00
AMRZ cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 38000000.00
AMRZ cash_flow (annual, 2022-12-31) — Changes In Cash: -36000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Common Stock Equity: 8209000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Construction In Progress: 403000000.00
AMRZ income_statement (annual, 2022-12-31) — Cost Of Revenue: 8254000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Assets: 3157000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 173000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Debt: 348000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 521000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 43000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 43000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Liabilities: 2251000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Current Provisions: 42000000.00
AMRZ cash_flow (annual, 2022-12-31) — Deferred Income Tax: 66000000.00
AMRZ cash_flow (annual, 2022-12-31) — Deferred Tax: 66000000.00
AMRZ cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 788000000.00
AMRZ income_statement (annual, 2022-12-31) — Diluted Average Shares: 552700000.00
AMRZ income_statement (annual, 2022-12-31) — Diluted EPS: 2.00
AMRZ income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1108000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 37000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 65000000.00
AMRZ income_statement (annual, 2022-12-31) — EBIT: 1708000000.00
AMRZ income_statement (annual, 2022-12-31) — EBITDA: 2496000000.00
AMRZ income_statement (annual, 2022-12-31) — Earnings From Equity Interest Net Of Tax: 13000000.00
AMRZ cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -12000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Employee Benefits: 250000000.00
AMRZ cash_flow (annual, 2022-12-31) — End Cash Position: 351000000.00
AMRZ cash_flow (annual, 2022-12-31) — Financing Cash Flow: 497000000.00
AMRZ cash_flow (annual, 2022-12-31) — Free Cash Flow: 1500000000.00
AMRZ cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -36000000.00
AMRZ income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 36000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -372000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Goodwill: 8115000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 9558000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 994000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Gross PPE: 15691000000.00
AMRZ income_statement (annual, 2022-12-31) — Gross Profit: 2472000000.00
AMRZ income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 57000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Income Tax Payable: 14000000.00
AMRZ income_statement (annual, 2022-12-31) — Interest Expense: 248000000.00
AMRZ income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 248000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Inventory: 1228000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Invested Capital: 16180000000.00
AMRZ cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2521000000.00
AMRZ cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1270000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Land And Improvements: 3251000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 516000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Long Term Debt: 7623000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 8139000000.00
AMRZ cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1270000000.00
AMRZ cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -385000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Long Term Provisions: 227000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 8562000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Minority Interest: 1000000.00
AMRZ income_statement (annual, 2022-12-31) — Minority Interests: 1000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -2033000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Net Debt: 7620000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Income: 1108000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1108000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1107000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1108000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1108000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1107000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1107000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Interest Income: -248000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 725000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 885000000.00
AMRZ income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -248000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -228000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -42000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Net PPE: 7753000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -446000000.00
AMRZ cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -160000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -1349000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 1197000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 253000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 944000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 250000000.00
AMRZ income_statement (annual, 2022-12-31) — Normalized EBITDA: 2517000000.00
AMRZ income_statement (annual, 2022-12-31) — Normalized Income: 1123729000.00
AMRZ balance_sheet (annual, 2022-12-31) — Notes Receivable: 336000000.00
AMRZ cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1988000000.00
AMRZ cash_flow (annual, 2022-12-31) — Operating Gains Losses: -29000000.00
AMRZ income_statement (annual, 2022-12-31) — Operating Income: 1720000000.00
AMRZ income_statement (annual, 2022-12-31) — Operating Revenue: 10726000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 552735960.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Current Assets: 51000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 348000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 224000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -372000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Equity Interest: 8581000000.00
AMRZ income_statement (annual, 2022-12-31) — Other Income Expense: -12000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1443000000.00
AMRZ cash_flow (annual, 2022-12-31) — Other Non Cash Items: -19000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 202000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 223000000.00
AMRZ income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 9000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Properties: 710000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Other Receivables: 74000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Payables: 1223000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1223000000.00
AMRZ cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 7000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 198000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Prepaid Assets: 117000000.00
AMRZ income_statement (annual, 2022-12-31) — Pretax Income: 1460000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Properties: 0.00
AMRZ cash_flow (annual, 2022-12-31) — Purchase Of Business: -2033000000.00
AMRZ cash_flow (annual, 2022-12-31) — Purchase Of PPE: -488000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Raw Materials: 516000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Receivables: 1410000000.00
AMRZ income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 8254000000.00
AMRZ income_statement (annual, 2022-12-31) — Reconciled Depreciation: 788000000.00
AMRZ cash_flow (annual, 2022-12-31) — Repayment Of Debt: -545000000.00
AMRZ cash_flow (annual, 2022-12-31) — Sale Of PPE: 42000000.00
AMRZ income_statement (annual, 2022-12-31) — Selling General And Administration: 752000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Share Issued: 552735960.00
AMRZ cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -160000000.00
AMRZ income_statement (annual, 2022-12-31) — Special Income Charges: -21000000.00
AMRZ cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Stockholders Equity: 8209000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Tangible Book Value: -1349000000.00
AMRZ income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -5271000.00
AMRZ income_statement (annual, 2022-12-31) — Tax Provision: 366000000.00
AMRZ income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.25
AMRZ balance_sheet (annual, 2022-12-31) — Total Assets: 20670000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Total Capitalization: 15832000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Total Debt: 8660000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 8210000000.00
AMRZ income_statement (annual, 2022-12-31) — Total Expenses: 9006000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12460000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 17513000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 10209000000.00
AMRZ income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1699000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Total Tax Payable: 14000000.00
AMRZ income_statement (annual, 2022-12-31) — Total Unusual Items: -21000000.00
AMRZ income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -21000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 173000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Work In Process: 712000000.00
AMRZ balance_sheet (annual, 2022-12-31) — Working Capital: 906000000.00
AMRZ income_statement (annual, 2023-12-31) — +Operating Expense: 898000000.00
AMRZ income_statement (annual, 2023-12-31) — +Total Revenue: 11677000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Accounts Payable: 1248000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1166000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -8322000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -49000000.00
AMRZ cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 162000000.00
AMRZ cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 162000000.00
AMRZ cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 15000000.00
AMRZ income_statement (annual, 2023-12-31) — Basic Average Shares: 552700000.00
AMRZ income_statement (annual, 2023-12-31) — Basic EPS: 1.73
AMRZ cash_flow (annual, 2023-12-31) — Beginning Cash Position: 351000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2885000000.00
AMRZ cash_flow (annual, 2023-12-31) — Capital Expenditure: -630000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 752000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 1107000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1107000000.00
AMRZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 734000000.00
AMRZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2025000000.00
AMRZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 2036000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Account Payable: 60000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Inventory: -7000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 8000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 142000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -32000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Payable: 88000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 88000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Receivables: -82000000.00
AMRZ cash_flow (annual, 2023-12-31) — Change In Working Capital: 117000000.00
AMRZ cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -83000000.00
AMRZ cash_flow (annual, 2023-12-31) — Changes In Cash: 745000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Common Stock Equity: 9203000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Construction In Progress: 522000000.00
AMRZ income_statement (annual, 2023-12-31) — Cost Of Revenue: 8908000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 81000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Assets: 3939000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 188000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Debt: 131000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 319000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 48000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 48000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Liabilities: 2443000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Current Provisions: 83000000.00
AMRZ cash_flow (annual, 2023-12-31) — Deferred Income Tax: 11000000.00
AMRZ cash_flow (annual, 2023-12-31) — Deferred Tax: 11000000.00
AMRZ cash_flow (annual, 2023-12-31) — Depreciation: 689000000.00
AMRZ cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 851000000.00
AMRZ cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 851000000.00
AMRZ income_statement (annual, 2023-12-31) — Diluted Average Shares: 552700000.00
AMRZ income_statement (annual, 2023-12-31) — Diluted EPS: 1.73
AMRZ income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 956000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 36000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 96000000.00
AMRZ income_statement (annual, 2023-12-31) — EBIT: 1852000000.00
AMRZ income_statement (annual, 2023-12-31) — EBITDA: 2703000000.00
AMRZ income_statement (annual, 2023-12-31) — Earnings From Equity Interest Net Of Tax: 13000000.00
AMRZ cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 11000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Employee Benefits: 259000000.00
AMRZ cash_flow (annual, 2023-12-31) — End Cash Position: 1107000000.00
AMRZ cash_flow (annual, 2023-12-31) — Financing Cash Flow: 734000000.00
AMRZ cash_flow (annual, 2023-12-31) — Free Cash Flow: 1406000000.00
AMRZ cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -32000000.00
AMRZ income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 32000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -317000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Goodwill: 8970000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 10854000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 1215000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Gross PPE: 16392000000.00
AMRZ income_statement (annual, 2023-12-31) — Gross Profit: 2769000000.00
AMRZ income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 15000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Income Tax Payable: 119000000.00
AMRZ income_statement (annual, 2023-12-31) — Interest Expense: 549000000.00
AMRZ income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 549000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Inventory: 1307000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Invested Capital: 17975000000.00
AMRZ cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2025000000.00
AMRZ cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1465000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Land And Improvements: 3430000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 564000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Long Term Debt: 8641000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9205000000.00
AMRZ cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1465000000.00
AMRZ cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -390000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Long Term Provisions: 245000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 8797000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
AMRZ income_statement (annual, 2023-12-31) — Minority Interests: 1000000.00
AMRZ cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -1607000000.00
AMRZ balance_sheet (annual, 2023-12-31) — Net Debt: 7665000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Income: 956000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 956000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 955000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 956000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 956000000.00
AMRZ cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 955000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 955000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Interest Income: -549000000.00
AMRZ cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 747000000.00
AMRZ cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 1075000000.00
AMRZ income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -549000000.00
AMRZ cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -13000000.00